Low-level laser therapy decreases renal interstitial fibrosis

Photomedicine and Laser Surgery

Volumn 30, Issue 12, 2012, Pages 705-713

  Oliveira, Fabiana Aparecida Mayrink ^a   Moraes, Ana Carolina Meneghin ^a   Paiva, Amanda Povoa ^a   Schinzel, Vĝnia ^a   Correa Costa, Matheus ^b,c   Semedo, Patricia ^c   Castoldi, Angêla ^c   Cenedeze, Marcos Antonio ^c   Oliveira, Roberto Sotto Maior Fortes ^a   Bastos, Marcus Gomes ^a   Cĝmara, Niels Olsen Saraiva ^b,c   Sanders Pinheiro, Helady ^a,b,c  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY DISEASE; EFFECTIVE THERAPY; IMMUNOHISTOCHEMICAL ANALYSIS; INTRA-OPERATIVE; KIDNEY FUNCTION; LOW LEVEL LASER THERAPY; MONOCYTE CHEMOTACTIC PROTEIN-1; MRNA EXPRESSION; MYOFIBROBLASTS; PROTECTIVE EFFECTS; RENAL FIBROSIS; RENAL INTERSTITIAL FIBROSIS; RENAL TISSUE; REVERSE-TRANSCRIPTASE POLYMERASE CHAIN REACTIONS; SIRIUS RED STAINING; TRANSDIFFERENTIATION; TRANSFORMING GROWTH FACTORS; WISTAR RAT;

ALUMINUM GALLIUM ARSENIDE; ANIMALS; CELL CULTURE; DIGITAL STORAGE; LASER TISSUE INTERACTION; LASERS; POLYMERASE CHAIN REACTION; TISSUE;

LASER SURGERY;

ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; LOW LEVEL LASER THERAPY; MALE; NEEDLE BIOPSY; NEPHRITIS, INTERSTITIAL; PATHOLOGY; PROCEDURES; RAT; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; BIOPSY, NEEDLE; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; LOW-LEVEL LIGHT THERAPY; MALE; NEPHRITIS, INTERSTITIAL; RATS; RATS, WISTAR; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84870469625     PISSN: 15495418     EISSN: None     Source Type: Journal    
DOI: 10.1089/pho.2012.3272     Document Type: Article

References (39)

1. Liu, Y. (2004). Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention. J. Am. Soc. Nephrol. 15, 1-12.
2. Bascands, J.L., and Schanstra, J.P. (2005). Obstructive nephropathy: Insights from genetically engineered animals. Kidney Int. 68, 925-937.
3. Fujiu, K., Manabe, I., and Nagai, R. (2011). Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J. Clin. Invest. 121, 3425-3441.
4. Klahr, S., and Morrissey, J. (2003). Progression of chronic renal disease. Am. J. Kidney Dis. 41, S3-S7.
5. Wynn, T.A. (2008). Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199-210.
6. Bani-Hani, A.H., Campbell, M.T., Meldrum, D.R., and Meldrum, K.K. (2008). Cytokines in epithelial-Mesenchymal transition: A new insight into obstructive nephropathy. J. Urol. 180, 461-468.
7. Qi, W., Chen, X., Poronnik, P., and Pollock, C.A. (2006). The renal cortical fibroblast in renal tubulointerstitial fibrosis. Int. J. Biochem. Cell. Biol. 38, 1-5.
8. Favreau, F., Thuillier, R., Cau, J., et al. (2010). Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model. Am. J. Transplant. 10, 30-39.
9. Klahr, S., and Morrissey, J. (2002). Obstructive nephropathy and renal fibrosis. Am. J. Physiol. Renal Physiol. 283, F861-F875.
10. Hruska, K.A. (2002). Treatment of chronic tubulointerstitial disease: A new concept. Kidney Int. 61, 1911-1922.
11. National Kidney Foundation (2002). K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am. J. Kidney Dis. 39, S1-S246.
12. Oron, A., Oron, U., Chen, J., et al. (2006). Low-level laser therapy applied transcranially to rats after induction of stroke significantly reduces long-term neurological deficits. Stroke 37, 2620-2624.
13. Rizzi, C.F., Mauriz, J.L., Freitas Correa, D.S., et al. (2006). Effects of low-level laser therapy (LLLT) on the nuclear factor (NF)-kappaB signaling pathway in traumatized muscle. Lasers Surg. Med. 38, 704-713.
14. Castro-e-Silva, O. Jr., Zucoloto, S., Marcassa, L.G., et al. (2003). Spectral response for laser enhancement in hepatic regeneration for hepatectomized rats. Lasers Surg. Med. 32, 50-53.
15. Oron, U., Yaakobi, T., Oron, A., et al. (2001). Low-energy laser irradiation reduces formation of scar tissue after myocardial infarction in rats and dogs. Circulation 103, 296-301.
16. Hu, W.P., Wang, J.J., Yu, C.L., Lan, C.C., Chen, G.S., and Yu, H.S. (2007). Helium-neon laser irradiation stimulates cell proliferation through photostimulatory effects in mitochondria. J. Invest. Dermatol. 127, 2048-2057.
17. Yaakobi, T., Shoshany, Y., Levkovitz, S., Rubin, O., Ben Haim, S.A., Oron, U. (2001). Long-term effect of low energy laser irradiation on infarction and reperfusion injury in the rat heart. J. Appl. Physiol. 90, 2411-2419.
18. Fillipin, L.I., Mauriz, J.L., Vedovelli, K., et al. (2005). Lowlevel laser therapy (LLLT) prevents oxidative stress and reduces fibrosis in rat traumatized Achilles tendon. Lasers Surg. Med. 37, 293-300.
19. Vieira, J.M.Jr., Mantovani, E., Rodrigues, L.T., et al. (2005). Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. Nephrol. Dial. Transplant. 20, 1582-1591.
20. Oliveira, A.F., Silva, T.C., Sankarankutty, A.K., et al. (2006). The effect of laser on remanescent liver tissue after 90% hepatectomy in rats. Acta Cir. Bras. 21, 29-32.
21. Correa-Costa, M., Semedo, P., Monteiro, A.P., et al. (2010). Induction of heme oxygenase-1 can halt and even reverse renal tubule-interstitial fibrosis. Plos One 5, e14298.
22. Grimm, P.C., Nickerson, P., Gough, J., et al. (2003). Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. J. Am. Soc. Nephrol. 14, 1662-1668.
23. Semedo, P., Correa-Costa, M., Antonio Cenedeze, M., et al. (2009). Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells 27, 3063-3073.
24. Oliveira, R.S.F., Oliveira, F.A.M., e Pinheiro, H.S. (2010). Programming image software for automatic selection of immunohistochemistry marked areas stained by dab chromogen and counter-stained by hematoxylin. Rev. Interdisciplin. Est. Exp. Anim. Hum. 2, 76-80.
25. BLAST (Basic Local Alignment Search Tool) from The National Center for Biotechnology Information at www.blast.ncbi .nlm.nih.gov
26. Chevalier, R.L., Forbes, M.S., and Thornhill, B.A. (2009). Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 75, 1145-1152.
27. Santos, L.F., Carvalho, A. A., Lea o, J.C., Cruz Perez, D.E., and Castro, J.F. (2011). Effect of low-level laser therapy in the treatment of burning mouth syndrome: A case series. Photomed. Laser Surg. 29, 793-796.
28. Vladimirov, Y.A., Osipov, A.N., and Klebanov, G.I. (2004). Photobiological principles of therapeutic applications of laser radiation. Biochemistry (Mosc) 69, 81-90.
29. Sweat, F., Puchtler, H., and Rosenthal, S.I. (1964). Sirius Red F3ba as a stain for connective tissue. Arch. Pathol. 78, 69-72.
30. Chen, C.O., Park, M.H., Forbes, M.S., et al. (2007). Angiotensin- converting enzyme inhibition aggravates renal interstitial injury resulting from partial unilateral ureteral obstruction in the neonatal rat. Am. J. Physiol. Renal Physiol. 292, F946-F955.
31. Belmiro, C.L., Goncalves, R.G., Kozlowski, E.O., et al. (2011). Dermatan sulfate reduces monocyte chemoattractant protein 1 and TGF-beta production, as well as macrophage recruitment and myofibroblast accumulation in mice with unilateral ureteral obstruction. Braz. J. Med. Biol. Res. 44, 624-633.
32. Matavelli, L.C., Huang, J., and Siragy, H.M. (2011). Angiotensin AT receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension 57, 308-313.
33. Sun, C.Y., Chang, S.C., and Wu, M.S. (2012). Uremic toxins induce kidney fibrosis by activating intrarenal reninangiotensin-Aldosterone system associated epithelial-tomesenchymal transition. Plos One 7, e34026
34. Phanish, M.K., Wahab, N.A., Colville-Nash, P., Hendry, B.M., and Dockrell, M.E. (2006). The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. Biochem. J. 393, 601-607.
35. Hwang, M., Kim, H.J., Noh, H.J., et al. (2006). TGF-beta1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction. Exp. Mol. Pathol. 81, 48-54.
36. Kawai, T., Masaki, T., Doi, S., et al. (2009). PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. Lab. Invest. 89, 47-58.
37. Yamamoto, T., Eckes, B., and Krieg, T. (2001). Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: Differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1. Biochem. Biophys. Res. Commun. 281, 200-205.
38. Li, M.X., and Liu, B.C. (2007). Epithelial to mesenchymal transition in the progression of tubulointerstitial fibrosis. Chin. Med. J. (Engl) 120, 1925-1930.
39. Kalluri, R., and Neilson, E.G. (2003) Epithelial-Mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112, 1776-1784